thioctic acid has been researched along with imidazolidines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nourooz-Zadeh, J; Ou, P; Tritschler, HJ; Wolff, S | 1 |
| Patel, J; Tomlinson, DR | 1 |
| Lang, HJ; Obrosova, IG; Stevens, MJ | 1 |
| Demiot, C; Fromy, B; Saumet, JL; Sigaudo-Roussel, D | 1 |
| Askwith, T; Eggo, MC; Stevens, MJ; Zeng, W | 1 |
| Dominguez, JM; Grant, MB; Yorek, MA | 1 |
6 other study(ies) available for thioctic acid and imidazolidines
| Article | Year |
|---|---|
Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
Topics: 1-Octanol; Aldehyde Reductase; Animals; Ascorbic Acid; Chelating Agents; Copper; Enzyme Activation; Enzyme Inhibitors; Erythrocytes; Fluorenes; Glucose; Humans; Hydantoins; Hydrogen Peroxide; Hyperglycemia; Imidazoles; Imidazolidines; In Vitro Techniques; Ions; Lens, Crystalline; Lipid Peroxidation; NADP; Octanols; Oxidation-Reduction; Phenanthrolines; Rats; Thioctic Acid | 1996 |
Nerve conduction impairment in experimental diabetes-proximodistal gradient of severity.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Combinations; Enzyme Inhibitors; gamma-Linolenic Acid; Imidazoles; Imidazolidines; Male; Neural Conduction; Neurons, Afferent; Polymers; Rabbits; Rats; Rats, Wistar; Sciatic Nerve; Severity of Illness Index; Sural Nerve; Thioctic Acid; Time Factors | 1999 |
Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy.
Topics: Adrenergic alpha-Antagonists; Ammonia; Animals; Antioxidants; Cell Fractionation; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Fructose; Glucose; Glutamic Acid; Imidazoles; Imidazolidines; Ketoglutaric Acids; Lactic Acid; Male; Mitochondria; NAD; Oxidation-Reduction; Piperazines; Prazosin; Pyrimidines; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Retina; Sorbitol; Thioctic Acid | 2001 |
Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice.
Topics: Acetylcholine; Aldehyde Reductase; Animals; Antioxidants; Biomarkers; Diabetes Mellitus; Dinoprost; Imidazolidines; Laser-Doppler Flowmetry; Male; Mice; Microcirculation; Nitric Oxide Synthase; Nitroarginine; Oxidative Stress; Pressure; Pressure Ulcer; Regional Blood Flow; Skin; Thioctic Acid; Vasodilation; Vasodilator Agents | 2006 |
Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.
Topics: Antioxidants; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Glucose; Humans; Imidazolidines; Male; MAP Kinase Signaling System; Membrane Glycoproteins; Membrane Transport Proteins; Molsidomine; Nitrates; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitroprusside; Nitrosation; RNA, Messenger; Schwann Cells; Taurine; Thioctic Acid | 2012 |
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats.
Topics: Adipose Tissue; Animals; Bone Marrow; Cytokines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fish Oils; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Hypoglycemic Agents; Imidazolidines; Inflammation; Insulin; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Neuropeptide Y; Nitric Oxide Synthase Type II; Pain Measurement; Rats; Rats, Sprague-Dawley; RNA, Messenger; Somatostatin; Stem Cells; Streptozocin; Thioctic Acid; Tyrosine 3-Monooxygenase | 2015 |